Stem Cell Assay Market is estimated to be US$ 6619.42 Million by 2030 with a CAGR of 19.8% during the forecast period
Stem Cell Assay Market accounted for US$ 1103.85
million in 2020 and is estimated to be US$ 6619.42 million by 2030 and is
anticipated to register a CAGR of 19.8%. Stem cells are special human cells
that are able to develop into many different cell types. This can range from
muscle cells to brain cells. In some cases, they can also fix damaged tissues.
Researchers believe that stem cell-based therapies may one day be used to treat
serious illnesses such as paralysis and Alzheimer disease. The only stem cells
now used to treat disease are hematopoietic stem cells. These are the blood
cell-forming adult stem cells found in bone marrow. Every type of blood cell in
the bone marrow starts as a stem cell. Stem cells are immature cells that are
able to make other blood cells that mature and function as needed.
The report " Global Stem Cell Assay Market,
By Type (Viability/Cytotoxicity, Isolation/Purification, Cell Identification,
Proliferation, Cell Differentiation, Cell Function, and Cell Apoptosis Assays),
By Kit (Adult Stem Cells Kit and Human Embryonic Stem Cells Kits), By Detection
(Instruments and Detection Kits), By Instrument (Flow Cytometer, Micro
Electrode Arrays, Cell Imaging Systems, and Automated Cell Counter), By
Application (Regenerative Medicine And Therapy Development, Drug Discovery
& Development, and Clinical Research), By End User (Government Research
Institutes, Private Research, and Industry Research), and By Region (North
America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends,
Analysis and Forecast till 2030”
Key Highlights:
·
On 24th July 2021, Edward Holland, MD, announced
the launch of the Holland Foundation for Site Restoration with a goal of
establishing Centers of Excellence (COEs) throughout the country that would
specialize in site restoration procedures.
·
In 2021,
Johnson & Johnson Vision announced the global launch of the Veritas Vision
System, a next-generation phacoemulsification system, according to a company
press release.
Analyst View:
The major factors boosting the growth of the
global stem cell assay market include rising expenditure in research-related
activities, advancement in technologies, and increased frequency of chronic
diseases. However, the growth of the market can be hindered owing to the huge
cost of stem cell-based therapies and strict regulatory recommendation. Rise in
approvals of clinical trials for stem cell based therapy, high prevalence of
chronic diseases, increase in research related activities in stem cells, and technological
advancements in the area of stem cell assays method supplements the growth of
the stem cell assay market.
To know the upcoming trends and insights
prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Stem-Cell-Assay-Market-3910
Key Market Insights from the report:
The Global Stem Cell Assay Market accounted for
US$ 1103.85 million in 2020 and is estimated to be US$ 6619.42 million by 2030
and is anticipated to register a CAGR of 19.8%. The Global Stem Cell Assay
Market is segmented based on the type, kit,
detection, instrument, application, end-user and region.
·
By Type, the
Global Stem Cell Assay Market is segmented into Viability/Cytotoxicity,
Isolation/Purification, Cell Identification, Proliferation, Cell
Differentiation, Cell Function, and Cell Apoptosis Assays.
·
By Kit, the
Global Stem Cell Assay Market is segmented into Adult Stem Cells Kit and Human
Embryonic Stem Cells Kits.
·
By Detection,
the Global Stem Cell Assay Market is segmented into Instruments and Detection
Kits.
·
By Instrument,
Global Stem Cell Assay Market is segmented into Flow Cytometer, Micro Electrode
Arrays, Cell Imaging Systems, and Automated Cell Counter.
·
By
Application, the Global Stem Cell Assay Market is segmented into Regenerative
Medicine and Therapy Development, Drug Discovery & Development, and
Clinical Research.
·
By End-User,
the Global Stem Cell Assay Market is segmented into Government Research
Institutes, Private Research, and Industry Research.
·
By region, the
Global Stem Cell Assay Market is segmented into North America, Europe, Asia Pacific,
Latin America, and Middle East & Africa. North America is the worldwide
leader in the stem cell assay market in terms of revenue, due to the developed
healthcare system and health awareness among people.
Competitive Landscape:
The key players operating the global stem cell
assay market involves GE Healthcare, Promega Corporation, Thermo Fisher
Scientific Inc., Merck KGaA, Cell Biolabs, Inc., Hemogenix, STEMCELL
Technologies Inc., Bio-Rad Laboratories Inc., R&D Systems Inc., and
Cellular Dynamics International Inc.
The market provides detailed information
regarding the industrial base, productivity, strengths, manufacturers, and
recent trends which will help companies enlarge the businesses and promote
financial growth. Furthermore, the report exhibits dynamic factors including
segments, sub-segments, regional marketplaces, competition, dominant key
players, and market forecasts. In addition, the market includes recent
collaborations, mergers, acquisitions, and partnerships along with regulatory
frameworks across different regions impacting the market trajectory. Recent
technological advances and innovations influencing the global market are
included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market
research, analytics, marketing/business strategy, and solutions that offers
strategic and tactical support to clients for making well-informed business
decisions and to identify and achieve high-value opportunities in the target
business area. We also help our clients to address business challenges and
provide the best possible solutions to overcome them and transform their
business.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.co
Comments
Post a Comment